These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 15604209

  • 1. Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta.
    Luo X, Ding L, Xu J, Chegini N.
    Endocrinology; 2005 Mar; 146(3):1097-118. PubMed ID: 15604209
    [Abstract] [Full Text] [Related]

  • 2. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy.
    Luo X, Ding L, Xu J, Williams RS, Chegini N.
    Endocrinology; 2005 Mar; 146(3):1074-96. PubMed ID: 15604208
    [Abstract] [Full Text] [Related]

  • 3. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
    Luo X, Ding L, Chegini N.
    Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
    [Abstract] [Full Text] [Related]

  • 4. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
    Luo X, Levens E, Williams RS, Chegini N.
    Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
    [Abstract] [Full Text] [Related]

  • 5. Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog.
    Xu J, Luo X, Chegini N.
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1350-61. PubMed ID: 12629129
    [Abstract] [Full Text] [Related]

  • 6. microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells.
    Pan Q, Luo X, Chegini N.
    Mol Hum Reprod; 2010 Mar; 16(3):215-27. PubMed ID: 19906824
    [Abstract] [Full Text] [Related]

  • 7. Regulation of transforming growth factor-beta1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells.
    Chegini N, Tang XM, Ma C.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4138-43. PubMed ID: 10566662
    [Abstract] [Full Text] [Related]

  • 8. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
    Levens E, Luo X, Ding L, Williams RS, Chegini N.
    Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
    [Abstract] [Full Text] [Related]

  • 9. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells.
    Ding L, Xu J, Luo X, Chegini N.
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5549-57. PubMed ID: 15531510
    [Abstract] [Full Text] [Related]

  • 10. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids.
    Pan Q, Luo X, Chegini N.
    J Cell Mol Med; 2008 Nov; 12(1):227-40. PubMed ID: 18182067
    [Abstract] [Full Text] [Related]

  • 11. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
    Chegini N, Rong H, Dou Q, Kipersztok S, Williams RS.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
    [Abstract] [Full Text] [Related]

  • 12. Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression.
    Chegini N, Ma C, Tang XM, Williams RS.
    Mol Hum Reprod; 2002 Dec; 8(12):1071-8. PubMed ID: 12468639
    [Abstract] [Full Text] [Related]

  • 13. The expression of transforming growth factor-beta s and TGF-beta receptor mRNA and protein and the effect of TGF-beta s on human myometrial smooth muscle cells in vitro.
    Tang XM, Dou Q, Zhao Y, McLean F, Davis J, Chegini N.
    Mol Hum Reprod; 1997 Mar; 3(3):233-40. PubMed ID: 9237249
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.
    Norian JM, Malik M, Parker CY, Joseph D, Leppert PC, Segars JH, Catherino WH.
    Reprod Sci; 2009 Dec; 16(12):1153-64. PubMed ID: 19700613
    [Abstract] [Full Text] [Related]

  • 17. Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma.
    Arici A, Sozen I.
    Am J Obstet Gynecol; 2003 Jan; 188(1):76-83. PubMed ID: 12548199
    [Abstract] [Full Text] [Related]

  • 18. Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3.
    Joseph DS, Malik M, Nurudeen S, Catherino WH.
    Fertil Steril; 2010 Mar 15; 93(5):1500-8. PubMed ID: 19328471
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells.
    Ohara N, Morikawa A, Chen W, Wang J, DeManno DA, Chwalisz K, Maruo T.
    Reprod Sci; 2007 Dec 15; 14(8 Suppl):20-7. PubMed ID: 18089606
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.